Lacosamide Tablet, Film Coated
Product Images NDC 58118-8815

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Lacosamide (NDC 58118-8815). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Clinical Solutions Wholesale, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lacosamide-fig1 (Lacosamide Fig1)

Bar chart displaying seizure reduction percentages from baseline across three Lacosamide clinical studies compared to placebo. Each study compares multiple Lacosamide dosages (mg/day) and corresponding patient numbers (N). The vertical axis shows median percentage seizure reduction, highlighting statistically significant improvements for Lacosamide versus placebo in all studies.*

FDA Label Image

Lacosamide-fig2 (Lacosamide Fig2)

This figure is a responder rate curve graph demonstrating patient response to Lacosamide at doses of 200 mg/day, 400 mg/day, and 600 mg/day compared to placebo. The x-axis shows the percent of patients, and the y-axis shows the responder rate from worsening to improvement. The graph includes lines for placebo and each dose level indicating relative patient outcomes.*

FDA Label Image

Lacosamide 50mg Tablets 30ct Blister Pack (Lacosamide Fig4)

Lacosamide 50 mg film-coated tablets packaging label. The label shows the quantity of 30 tablets and includes the NDC number 58118-8812-8. Manufactured by Camber Pharmaceuticals in Piscataway, NJ, and labeled by Clinical Solutions Wholesale, LLC. The label contains a barcode, expiration date of March 2027, and batch information.*

FDA Label Image

Lacosamide 100mg Tablets 30ct Blister Pack (Lacosamide Fig5)

Packaging label for Lacosamide 100 mg film-coated tablets by Clinical Solutions Wholesale, LLC. The label indicates a quantity of 30 tablets, includes NDC 58118-8813-8, and lists manufacturer information for Camber Pharmaceuticals in Piscataway, NJ. The label also shows batch number, expiration date of March 2027, and repackaging details.*

FDA Label Image

Lacosamide 150mg Tablets 30ct Blister Pack (Lacosamide Fig6)

Lacosamide 150 mg film-coated tablets packaging label from Clinical Solutions Wholesale, LLC. The label includes the NDC 58118-8814-8 and indicates a quantity of 30 tablets. Manufactured by Camber Pharmaceuticals in Piscataway, NJ, with sample manufacturing and batch numbers. The label also states repackaging and distribution information by Clinical Solutions Wholesale.*

FDA Label Image

Lacosamide 200mg Tablets 30ct Blister Pack (Lacosamide Fig7)

Lacosamide 200 mg tablets packaging label from Clinical Solutions Wholesale. The label shows the quantity as 30 tablets, lists the NDC as 58118-8815-8, and includes manufacturing information for Camber Pharmaceuticals in Piscataway, NJ, USA. It also states the lot number SAMPLE123 and expiration date March 2027.*

FDA Label Image

Lacosamide-logo1 (Lacosamide Logo1)

FDA Label Image

Lacosamide-logo2 (Lacosamide Logo2)

FDA Label Image

Lacosamide-str (Lacosamide Str)

Chemical structure diagram of lacosamide, showing its molecular arrangement including an acetyl group, amide bonds, a methoxy group, and a benzyl group, consistent with the active ingredient lacosamide.*

FDA Label Image

Lacosamideosfigure3 (Lacosamideosfigure3)

A Kaplan-Meier survival curve comparing Lacosamide and placebo groups over time in days. The graph shows the proportion of patients on the vertical axis and time (days) on the horizontal axis, illustrating differences in survival or event-free rates between the two groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.